Vericel (VCEL) Amortization of Deferred Charges (2019 - 2026)
Vericel's (VCEL) quarterly Amortization of Deferred Charges came in at $54000.0 in Q1 2026, little changed year-on-year from $54000.0 in Q1 2025, and little changed quarter-over-quarter from $54000.0 in Q4 2025.
Vericel (VCEL) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
Vericel has disclosed Amortization of Deferred Charges across 8 years of filings, most recently posting $54000.0 for Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at $54000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $215000.0 (changed 0.0% YoY), and the FY2025 annual result was $215000.0, changed 0.0% from the prior year.
- Amortization of Deferred Charges came in at $54000.0 for Q1 2026 at Vericel, roughly flat from $54000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $54000.0 in Q4 2022 to a low of $36000.0 in Q3 2022.
- The 5-year median for Amortization of Deferred Charges is $54000.0 (2022), against an average of $52600.0.
- Across the five-year window, Amortization of Deferred Charges soared 101.55% in 2022 and changed 0.0% in 2023, its largest moves.
- Vericel's Amortization of Deferred Charges stood at $54000.0 in 2022, then changed by 0.0% to $54000.0 in 2023, then changed by 0.0% to $54000.0 in 2024, then changed by 0.0% to $54000.0 in 2025, then changed by 0.0% to $54000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $54000.0 (Q1 2026), $54000.0 (Q4 2025), and $53000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54,000.00 |
| Mar 31, 2026 | 54,000.00 |
| Dec 31, 2025 | 54,000.00 |
| Dec 31, 2025 | 54,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 54,000.00 |
| Dec 31, 2023 | 54,000.00 |